1477 First efficacy and multi-omic analysis data from phase 1 clinical trial of oncolytic viral immunotherapy with CAN-2409 + valacyclovir in combination with nivolumab and standard of care in newly diagnosed high-grade glioma Patrick Wen , Caroline Duault , Edgar Gonzalez-Kozlova , Kevin Brennan , Tyson Holmes , Seunghee Kim-Schulze , Kai Nie , Kimberly Argueta , Jacques Fehr , Mina Pichavant , Diane Del Valle , Andrew Gentles , Sacha Gnjatic , Holden Maecker , Xiaobu Ye , David Reardon , Wenya Linda Bi , Pierpaolo Peruzzi , Nirav Patel , Roy Strowd , Stephen Tatter , Ian Lee , Tobias Walbert , James Snyder , Steven Brem , Arati Desai , Stephen Bagley , Nduka Amankulor , Frank Lieberman , Megan Mantica , Lenika Lopez , Susan Bell , Andrea Manzanera , Sean Lawler , Lixian Jin , Neeraja Danda , Serena Desideri , L Burt Nabors , Stuart Grossman , E Chiocca , Paul Tak , Francesca Barone Late-Breaking Abstracts（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
